Aqua Bio Technology ASA (FRA:3FZ0) Cyclically Adjusted Revenue per Share: €1.74 (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:3FZ0 Aqua Bio Technology ASA FRA:3FZ0
39 GF Score
Price €0.41
GF Value €0.32
Valuation Modestly Overvalued
! 5 Warning Signs
View Full Analysis

What is Aqua Bio Technology ASA Cyclically Adjusted Revenue per Share?

Aqua Bio Technology ASA FRA:3FZ0 -4.87% 39 Cyclically Adjusted Revenue per Share is €1.74 as of Dec. 2025. GuruFocus rates FRA:3FZ0 with a GF Score™ of 39/100 and a GF Value™ of €0.32 (Modestly Overvalued). The stock has 5 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Aqua Bio Technology ASA's adjusted revenue per share for the three months ended in Dec. 2025 was €-0.184. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is €1.74 for the trailing ten years ended in Dec. 2025.

During the past 12 months, Aqua Bio Technology ASA's average Cyclically Adjusted Revenue Growth Rate was -1.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

As of today (2026-07-29), Aqua Bio Technology ASA's current stock price is €0.41. Aqua Bio Technology ASA's Cyclically Adjusted Revenue per Share for the quarter that ended in Dec. 2025 was €1.74. Aqua Bio Technology ASA's Cyclically Adjusted PS Ratio of today is 0.24.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Aqua Bio Technology ASA was 9.74. The lowest was 0.27. And the median was 1.61.


Aqua Bio Technology ASA  (FRA:3FZ0) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Aqua Bio Technology ASA's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=0.41/1.74
=0.24

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Aqua Bio Technology ASA was 9.74. The lowest was 0.27. And the median was 1.61.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Aqua Bio Technology ASA Cyclically Adjusted Revenue per Share Related Terms


Aqua Bio Technology ASA Cyclically Adjusted Revenue per Share Historical Data

* Premium members only.

The historical data trend for Aqua Bio Technology ASA's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Aqua Bio Technology ASA Cyclically Adjusted Revenue per Share Chart

Aqua Bio Technology ASA Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 1.44 1.74

Aqua Bio Technology ASA Quarterly Data
Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Sep24 Dec24 Jun25 Sep25 Dec25
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.50 1.44 0.00 1.01 1.74

FRA:3FZ0 vs VRTX, REGN, RVMD: Cyclically Adjusted Revenue per Share Comparison

For the Biotechnology subindustry, Aqua Bio Technology ASA's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Aqua Bio Technology ASA Cyclically Adjusted PS Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Aqua Bio Technology ASA's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Aqua Bio Technology ASA's Cyclically Adjusted PS Ratio falls into.


FRA:3FZ0
39GF Score
Aqua Bio Technology ASA FRA:3FZ0
Cyclically Adjusted Revenue per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Aqua Bio Technology ASA Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Aqua Bio Technology ASA's adjusted Revenue per Share data for the three months ended in Dec. 2025 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Dec. 2025 (Change)*Current CPI (Dec. 2025)
=-0.184/139.1000*139.1000
=-0.184

Current CPI (Dec. 2025) = 139.1000.

Aqua Bio Technology ASA Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201203 0.991 94.100 1.465
201206 0.148 93.700 0.220
201209 0.215 93.900 0.318
201212 0.000 94.700 0.000
201303 0.457 95.400 0.666
201306 3.128 95.700 4.547
201309 0.226 96.400 0.326
201312 0.295 96.600 0.425
201403 0.519 97.300 0.742
201406 0.292 97.500 0.417
201409 0.487 98.500 0.688
201412 -0.380 98.600 -0.536
201503 0.129 99.200 0.181
201506 0.000 100.100 0.000
201509 0.115 100.600 0.159
201512 0.058 100.900 0.080
201603 0.000 102.500 0.000
201606 0.000 103.800 0.000
201609 0.000 104.200 0.000
201612 0.000 104.400 0.000
201706 0.000 105.800 0.000
201712 0.000 106.100 0.000
201806 0.000 108.500 0.000
201812 0.000 109.800 0.000
201906 0.000 110.600 0.000
201912 0.000 111.300 0.000
202006 0.000 112.100 0.000
202012 0.000 112.900 0.000
202106 0.000 115.300 0.000
202112 0.000 118.900 0.000
202206 0.000 122.600 0.000
202212 0.000 125.900 0.000
202306 0.000 130.400 0.000
202312 0.000 131.900 0.000
202406 0.000 133.800 0.000
202409 0.425 133.700 0.442
202412 -0.398 134.800 -0.411
202506 0.000 137.800 0.000
202509 0.061 138.500 0.061
202512 -0.184 139.100 -0.184

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

What does a Cyclically Adjusted Revenue per Share of €1.74 mean?
Aqua Bio Technology ASA (FRA:3FZ0) has a Cyclically Adjusted Revenue per Share of €1.74 as of Dec. 2025. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Aqua Bio Technology ASA and its competitors.
Is Aqua Bio Technology ASA's Cyclically Adjusted Revenue per Share too high?
Aqua Bio Technology ASA's current Cyclically Adjusted Revenue per Share is €1.74. Overall, Aqua Bio Technology ASA has a GF Score™ of 39/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Aqua Bio Technology ASA's Cyclically Adjusted Revenue per Share compare to VRTX and REGN?
Aqua Bio Technology ASA's Cyclically Adjusted Revenue per Share of €1.74 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Revenue per Share for a Biotechnology company?
A good Cyclically Adjusted Revenue per Share depends on the Biotechnology industry context. However, Cyclically Adjusted Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Revenue per Share mean?
A high Cyclically Adjusted Revenue per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Aqua Bio Technology ASA and its competitors. Aqua Bio Technology ASA's current Cyclically Adjusted Revenue per Share is €1.74. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Aqua Bio Technology ASA stock overvalued right now?
Based on GuruFocus' analysis, Aqua Bio Technology ASA (FRA:3FZ0) is currently considered Modestly Overvalued. The stock's GF Value™ is €0.32, compared to a current price of €0.41 — trading 28.1% above its estimated fair value. The current Cyclically Adjusted Revenue per Share is €1.74. Aqua Bio Technology ASA's overall GF Score™ is 39/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Revenue per Share calculated?
Cyclically Adjusted Revenue per Share is calculated from a company's financial statements. For Aqua Bio Technology ASA (FRA:3FZ0), the current Cyclically Adjusted Revenue per Share is €1.74 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Aqua Bio Technology ASA (FRA:3FZ0) Overvalued in 2026?

Based on GuruFocus' analysis, Aqua Bio Technology ASA stock appears to be overvalued. The current stock price of €0.41 is trading 28.1% above its estimated GF Value™ of €0.32. GuruFocus considers Aqua Bio Technology ASA to be Modestly Overvalued.

Key valuation signals for FRA:3FZ0:

  • Cyclically Adjusted Revenue per Share: €1.74
  • GF Value™: €0.32 vs. price of €0.41 (28.1% above fair value)
  • GF Score™: 39/100 with 5 warning signs

No single metric tells the full story. See the FRA:3FZ0 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Aqua Bio Technology ASA Business Description

Address Bygdoy Alle, Oslo, NOR, 0257
Aqua Bio Technology ASA develops, produces and markets active ingredients for the personal care industry. It creates products for personal care, healthcare, and cosmetics with the help of marine biotechnology. ABT's brands include Moana-Organic skin care and Cuvget-Arctic skin care.
39GF Score

Get the complete analysis for FRA:3FZ0

Cyclically Adjusted Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.41
Price
€0.32
GF Value